Clinical Pearls for Community Oncologists Treating Patients With Advanced Endometrial Cancer
December 26th 2023Floor Backes, MD, closes the discussion by explaining that endometrial cancer care is rapidly evolving and complicated, requiring calling on colleagues for guidance, getting molecular profiling, and encouraging trial participation.
Read More
Unmet Needs in the Management of Patients With Advanced Endometrial Cancer
December 26th 2023Looking ahead, Floor Backes, MD, notes that key needs in the treatment of advanced endometrial cancer are figuring out next steps when immunotherapy resistance develops, targeted radiation for oligometastatic disease, and sorting patients into subgroups for personalize care.
Read More
Adverse Events Seen With Systemic Therapies in Patients With Advanced Endometrial Cancer
December 18th 2023Drs Backes and Powell discuss the management of adverse events between upfront immunotherapy versus chemotherapy followed by later immunotherapy for endometrial cancer, noting the need for molecular subgroup data from trials like LEAP-001.
Read More
The Impact of Real-World Evidence on the Treatment of Patients With Advanced Endometrial Cancer
December 11th 2023Matthew Powell, MD, and Floor Backes, MD, discuss real-world evidence from recent trials confirming benefit of immunotherapies in practice for patients with advanced endometrial cancer.
Read More
Drs Powell and Backes discuss additional immunotherapy trial results from ESMO 2023 including AtTEnd and DUO-E, noting differences across trials likely due to patient population composition rather than drug differences, and need for caution with PARP inhibitor maintenance.
Read More
Matthew Powell, MD, and Floor Backes, MD, enthusiastically discuss the practice-changing RUBY trial results presented at the 2023 ESMO Congress showing impressive survival benefits with immunotherapy plus chemotherapy for both MMR-deficient and MMR-proficient advanced endometrial cancer.
Read More
Dr. Backes on the Utility of Sentinel Lymph Node Mapping in Cervical Cancer
May 24th 2019Floor J. Backes, MD, associate professor, Division of Gynecologic Oncology, at The Ohio State University Comprehensive Cancer Center, discusses the utility of sentinel lymph node mapping in patients with cervical cancer.
Read More
Dr. Backes on Sentinel Lymph Node Mapping in Cervical Cancer
April 29th 2019Floor J. Backes, MD, associate professor, Division of Gynecologic Oncology, at The Ohio State University Comprehensive Cancer Center, discusses the use of sentinel lymph node mapping in patients with cervical cancer.
Read More